To investigate the mechanisms underpinning the modulation of spastic hypertonia by Sativex, at both central and spinal levels, through an extensive neurophysiological battery in patients with Multiple sclerosis.
Phase of Trial: Phase II
Latest Information Update: 09 Jun 2017
At a glance
- Drugs Nabiximols (Primary)
- Indications Multiple sclerosis
- Focus Therapeutic Use
- 09 Jun 2017 New trial record